Summary
Serum bone Gla-protein (sBGP) was measured in 32 patients with untreated Paget's disease of bone. Despite clinical and biological symptoms of active disease in all patients, sBGP was normal in 13/32 patients (41%). There was a striking discrepancy between the moderate increase of sBGP above normal values (11.4±4.5 vs 6.0±2.1 ng/ml) and the marked increase of both serum alkaline phosphatase (sAP) and urinary hydroxyproline (uOHP). sBGP was weakly correlated with sAP (r=0.50, p<0.01), uOHP (r=0.48, p<0.01) and with the extension of the disease (r=0.48, p<0.01), We conclude that sBGP is not a sensitive marker of bone turnover in patients with Paget's disease of bone, and should be interpreted with caution in this condition.
References
PRICE P. A., PARTHEMORE J.G., DEFTOS L. J. (1980). New Biochemical Marker for Bone Metabolism. J. Clin. Invest. 66: 878–83
DEFTOS L. J., PARTHEMORE J. G., PRICE P. A., (1982). Changes in Plasma Bon Gla Protein during Treatment of Bone Disease. Calcif Tissue Int. 34: 121–124
GUNDBERG C. M., LIAN J. M., GALLOP P. M., STEINBERG J. J. (1983). Urinary γ Carboxyglutamic Acid and Serum Osteocalcin as Bone Markers: Studies in Osteoporosis and Paget's disease. J. Clin Endocrinol Metab. 57: 1221–1225
DELMAS P. D., WAHNER H. W., MANN K. G., RIGGS B. L. (1983). Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J. Lab. Clin. Med. 102: 470–476
MEUNIER P. J., COINDRE J. M., EDOUARD C. M., ARLOT M. E. (1980). Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthr. and Rheum. 23: 1095–1103
DELMAS P. D., STENNER D., WAHNER H. W., MANN K. G., RIGGS B. L. (1983) Increase in serum bone carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J. Clin. Invest. 71: 1316–1321
COUTRIS G., CAYLA Y., RONDIER J., TALBOT J. N., BONVARLET J. P., MILHAUD G. (1975). Analyse des perturbations des voies principales du métabolisme calcique dans la maladie de Paget. Rev. Rhum. 42: 759–767
PRICE P. A., WILLIAMSON M. K. (1981) Effects of Warfarin on Bone. J. Biol. Chem. 256: 12754–12759
BROWN J. P., DELMAS P. D., MALAVAL L., EDOUARD C., CHAPUY M. C., MEUNIER P. J., (1984). Serum Bone Gla-protein: a specific marker for bone formation in post menopausal osteoporosis. Lancet i 1091–1093
POSEN S., GRUNSTEIN H. S. (1982) Turnover rates of skeletal alkaline phosphatase in humans. Clin. Chem. 28: 153–154
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Delmas, P.D., Demiaux, B., Malaval, L. et al. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue Int 38, 60–61 (1986). https://doi.org/10.1007/BF02556596
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02556596